Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancerDomenico Albino(Institute of Oncology Research), Giuseppina M. Carbone(Institute of Oncology Research)Communications BiologyJanuary 26, 202110.1038/s42003-020-01642-5Cited by 42SaveCiteExport RISWatch citationsRelated PapersEpigenome-wide impact of MAT2A sustains the androgen-indifferent state and confers synthetic vulnerability in ERG fusion-positive prostate cancer|Nature Communications|2024|10